These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9568061

  • 1. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
    van Waardenburg RC, Meijer C, Pinto-Sietsma SJ, de Vries EG, Timens W, Mulder NM.
    Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
    [Abstract] [Full Text] [Related]

  • 2. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC, Prins J, Meijer C, Uges DR, De Vries EG, Mulder NH.
    Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
    [Abstract] [Full Text] [Related]

  • 3. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF, Campbell SE, Bochner BS, Dang CV.
    Cancer Res; 1998 Dec 01; 58(23):5537-45. PubMed ID: 9850091
    [Abstract] [Full Text] [Related]

  • 4. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G, Bading H, Heimann B, Kiefer P, Havemann K, Moelling K.
    Oncogene; 1989 Jan 01; 4(1):45-50. PubMed ID: 2536917
    [Abstract] [Full Text] [Related]

  • 5. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
    Doyle LA, Mabry M, Stahel RA, Waibel R, Goldstein LH.
    Br J Cancer Suppl; 1991 Jun 01; 14():39-42. PubMed ID: 1645569
    [Abstract] [Full Text] [Related]

  • 6. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec 01; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J, De Vries EG, Mulder NH.
    Anticancer Res; 1993 Dec 01; 13(5A):1373-85. PubMed ID: 8239508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
    Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG.
    Cancer Res; 1988 Dec 01; 48(23):6803-7. PubMed ID: 2846161
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
    Dosaka-Akita H, Akie K, Hiroumi H, Kinoshita I, Kawakami Y, Murakami A.
    Cancer Res; 1995 Apr 01; 55(7):1559-64. PubMed ID: 7882365
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line.
    Walker C, Wright-Perkins S.
    Oncol Res; 1992 Apr 01; 4(10):419-29. PubMed ID: 1337994
    [Abstract] [Full Text] [Related]

  • 15. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
    Shivapurkar N, Reddy J, Matta H, Sathyanarayana UG, Huang CX, Toyooka S, Minna JD, Chaudhary PM, Gazdar AF.
    Oncogene; 2002 Dec 05; 21(55):8510-4. PubMed ID: 12466971
    [Abstract] [Full Text] [Related]

  • 16. Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatment.
    Fokkema E, De Vries EG, Groen HJ, Meijer C, Timens W.
    Virchows Arch; 2003 Apr 05; 442(4):349-55. PubMed ID: 12715170
    [Abstract] [Full Text] [Related]

  • 17. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH, Girard L, Giacomini CP, Wang P, Hernandez-Boussard T, Tibshirani R, Minna JD, Pollack JR.
    Oncogene; 2006 Jan 05; 25(1):130-8. PubMed ID: 16116477
    [Abstract] [Full Text] [Related]

  • 18. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells.
    Kimura S, Maekawa T, Hirakawa K, Murakami A, Abe T.
    Cancer Res; 1995 Mar 15; 55(6):1379-84. PubMed ID: 7882339
    [Abstract] [Full Text] [Related]

  • 19. Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.
    Pfeifer AM, Jones RT, Bowden PE, Mann D, Spillare E, Klein-Szanto AJ, Trump BF, Harris CC.
    Cancer Res; 1991 Jul 15; 51(14):3793-801. PubMed ID: 1712250
    [Abstract] [Full Text] [Related]

  • 20. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H, Catlett J, Leftwich J, Armstrong B, Carlson P, Huff T, Krystal G.
    Cancer Res; 1993 Sep 15; 53(18):4337-42. PubMed ID: 7689933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.